शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSECENTUPLE GLOBAL LIMITED· Pharmaceuticals & BiotechnologyHighNeutral
Announced Thu, 13 Aug, 2026 · 18:04 IST

Q1 FY27 results: zero revenue, edible oil trading halted

Revenue DeclinePat NegativeEmphasis Of MatterRelated Party TransactionsResults View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-14.1%Reaction day
₹52.40
prior close
₹48.50
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-14.2% vs market
Pharmaceuticals peers, median of 166sector-0.4%-13.7% vs sector

On the reaction day the stock moved 14.2 pts less than Nifty Microcap 250 and 13.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
+0.0
15m
+13.4
30m
+11.1
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-14.1+0.1-14.2-0.4-13.7
Next day
-21.8+0.2-22.0-0.3-21.4
2d
-26.5+0.6-27.1-0.5-26.0
3d
-30.2-0.0-30.2-1.3-28.9
4d
-33.6+0.5-34.1-0.8-32.8
5d
-30.4+0.8-31.2-0.4-30.1
1w
-29.4+0.6-30.0-0.9-28.5
15d
-31.8+1.3-33.1+0.0-31.9
1m
-33.5-1.4-32.1-0.1-33.4
2m
-41.7-0.6-41.1-2.6-39.1
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 166Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Centuple Global reported zero revenue for Q1 FY27 (quarter ended June 30, 2026) versus 1,171.27 lakhs in Q1 FY25. The company halted all edible oil trading during the quarter due to poor domestic and international market conditions. Net loss stood at 18.39 lakhs versus a profit of 8.89 lakhs a year ago. Auditor L K Ajmera issued an unmodified review with an emphasis of matter flagging the subdued trading. The board also approved a related party transaction and a loan from a director.

Likely market impact

Zero revenue and a loss mark a sharp downturn. The complete halt in edible oil trading raises concerns about near-term business viability.